Molecular imaging using PET for breast cancer

被引:17
作者
Kurihara, Hiroaki [1 ]
Shimizu, Chikako [2 ]
Miyakita, Yasuji [3 ]
Yoshida, Masayuki [4 ]
Hamada, Akinobu [5 ]
Kanayama, Yousuke [6 ]
Yonemori, Kan [2 ]
Hashimoto, Jun [2 ]
Tani, Hitomi [1 ]
Kodaira, Makoto [2 ]
Yunokawa, Mayu [2 ]
Yamamoto, Harukaze [2 ]
Watanabe, Yasuyoshi [6 ]
Fujiwara, Yasuhiro [2 ]
Tamura, Kenji [2 ]
机构
[1] Natl Canc Ctr, Dept Diagnost Radiol, Chuo Ku, Tokyo 1040045, Japan
[2] Natl Canc Ctr, Dept Breast & Med Oncol, Tokyo 1040045, Japan
[3] Natl Canc Ctr, Dept Neurosurg, Tokyo 1040045, Japan
[4] Natl Canc Ctr, Dept Pathol & Clin Labs, Tokyo 1040045, Japan
[5] Natl Canc Ctr, Res Inst, Dept Clin Pharmacol Grp, Translat Res Support Core, Tokyo 104, Japan
[6] RIKEN, Ctr Mol Imaging Sci, Kobe, Hyogo, Japan
关键词
Breast cancer; PET; Molecular imaging; Molecular target therapy; HER2; POSITRON-EMISSION-TOMOGRAPHY; ESTROGEN-RECEPTOR; FDG-PET; WHOLE-BODY; NEOADJUVANT CHEMOTHERAPY; ADJUVANT CHEMOTHERAPY; F-18-FDG PET; TRASTUZUMAB; TUMOR; EXPRESSION;
D O I
10.1007/s12282-015-0613-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Molecular imaging can visualize the biological processes at the molecular and cellular levels in vivo using certain tracers for specific molecular targets. Molecular imaging of breast cancer can be performed with various imaging modalities, however, positron emission tomography (PET) is a sensitive and non-invasive molecular imaging technology and this review will focus on PET molecular imaging of breast cancer, such as FDG-PET, FLT-PET, hormone receptor PET, and anti-HER2 PET.
引用
收藏
页码:24 / 32
页数:9
相关论文
共 80 条
[11]   Multimodality imaging of the HER-kinase axis in cancer [J].
Cai, Weibo ;
Niu, Gang ;
Chen, Xiaoyuan .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (01) :186-208
[12]   MicroPET and autoradiographic imaging of breast cancer αv-integrin expression using 18F- and 64Cu-labeled RGD peptide [J].
Chen, XY ;
Park, R ;
Tohme, M ;
Shahinian, AH ;
Bading, JR ;
Conti, PS .
BIOCONJUGATE CHEMISTRY, 2004, 15 (01) :41-49
[13]  
DEHDASHTI F, 1995, J NUCL MED, V36, P1766
[14]  
DEHDASHTI F, 1991, J NUCL MED, V32, P1532
[15]   Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer [J].
Dijkers, E. C. ;
Munnink, T. H. Oude ;
Kosterink, J. G. ;
Brouwers, A. H. ;
Jager, P. L. ;
de Jong, J. R. ;
van Dongen, G. A. ;
Schroder, C. P. ;
Lub-de Hooge, M. N. ;
de Vries, E. G. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 (05) :586-592
[16]   Immunoscintigraphy as Potential Tool in the Clinical Evaluation of HER2/neu Targeted Therapy [J].
Dijkers, Eli C. F. ;
de Vries, Elisabeth G. E. ;
Kosterink, Jos G. W. ;
Brouwers, Adrienne H. ;
Hooge, Marjolijn N. Lub-de .
CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (31) :3348-3362
[17]   Contrast-enhanced ultrasound for molecular imaging of angiogenesis [J].
Eisenbrey, J. R. ;
Forsberg, F. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 :S138-S146
[18]   PET and PET/CT using 18F-FDG in the diagnosis and management of cancer patients [J].
Endo K. ;
Oriuchi N. ;
Higuchi T. ;
Iida Y. ;
Hanaoka H. ;
Miyakubo M. ;
Ishikita T. ;
Koyama K. .
International Journal of Clinical Oncology, 2006, 11 (4) :286-296
[19]   Recommendations on the use of 18F-FDG PET in oncology [J].
Fletcher, James W. ;
Djulbegovic, Benjamin ;
Soares, Heloisa P. ;
Siegel, Barry A. ;
Lowe, Val J. ;
Lyman, Gary H. ;
Coleman, R. Edward ;
Wahl, Richard ;
Paschold, John Christopher ;
Avrill, Norbert ;
Einhorn, Lawrence H. ;
Suh, W. Warren ;
Samson'O, David ;
Delbekell, Dominique ;
Gorman, Mark ;
Shields, Anthony F. .
JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (03) :480-508
[20]   89Zr- Bevacizumab PET Imaging in Primary Breast Cancer [J].
Gaykema, Sietske B. M. ;
Brouwers, Adrienne H. ;
Lub-de Hooge, Marjolijn N. ;
Pleijhuis, Rick G. ;
Timmer-Bosscha, Hetty ;
Pot, Linda ;
van Dam, Gooitzen M. ;
van der Meulen, Sibylle B. ;
de Jong, Johan R. ;
Bart, Joost ;
de Vries, Jakob ;
Jansen, Liesbeth ;
de Vries, Elisabeth G. E. ;
Schroder, Carolien P. .
JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (07) :1014-1018